Diethylstilbestrol exposure

American Family Physician

Volumn 69, Issue 10, 2004, Pages 2395-2402

  Schrager, Sarina ^a   Potter, Beth E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; ADULT; BREAST CANCER; CANCER SCREENING; CASE REPORT; COLPOSCOPY; CONSULTATION; DRUG EXPOSURE; ECTOPIC PREGNANCY; FEMALE; FOOD AND DRUG ADMINISTRATION; GENITAL MALFORMATION; GYNECOLOGICAL EXAMINATION; HIGH RISK POPULATION; HUMAN; INFERTILITY; MALE; MAMMOGRAPHY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PROSTATE CANCER; REVIEW; SELF EXAMINATION; SPONTANEOUS ABORTION; TESTIS CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VAGINA CARCINOMA; VAGINA CYTOLOGY;

BREAST NEOPLASMS; DIETHYLSTILBESTROL; ESTROGENS, NON-STEROIDAL; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 2442676607     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance of male and female offspring. Am J Obstet Gynecol 1982;142:905-21.
2. Centers for Disease Control and Prevention. DES update. Accessed online February 19, 2004, at: http://www.cdc.gov/DES.
3. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995;122:778-88.
4. Exposure in utero to diethylstilbestrol and related synthetic hormones. Association with vaginal and cervical cancers and other abnormalities. JAMA 1976;236:1107-9.
5. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-81.
6. Walker BE, Haven MI. Intensity of multigenerational carcinogenesis from diethylstilbestrol in mice. Carcinogenesis 1997;18:791-3.
7. Kaufman RH, ed. Physician information. How to identify and manage DES exposed individuals. Bethesda, Md.: National Cancer Institute, 1995; NIH publication no. 81-2049.
8. Kruse K, Lauver D, Hanson K. Clinical implications of DES. Nurse Pract 2003;28(7 pt 1):26-32,35.
9. Jackson R, O'Donnell L, Johnson C, Dietrich AJ, Lauridsen J, O'Donnell C. Office systems intervention to improve diethylstilbestrol screening in managed care. Obstet Gynecol 2000;96:380-4.
10. Colton T, Greenberg ER, Noller K, Resseguie L, Van Bennekom C, Heeren T, et al. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA 1993;269:2096-100.
11. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
12. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:900-9.
13. Melnick S, Cole P, Anderson D, Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med 1987;316:514-6.
14. Hanselaar A, van Loosbroek M, Schuurbiers O, Helmerhorst T, Bulten J, Bernheim J. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer 1997;79:2229-36.
15. Kaminski PF, Maier RC. Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet Gynecol 1983;62:720-7.
16. Hatch EE, Palmer JR, Titus-Ernstoff L, Noller KL, Kaufman RH, Mittendorf R, et al. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 1998;280:630-4.
17. Robboy SJ, Szyfelbein WM, Goellner JR, Kaufman RH, Taft PD, Richard RM, et al. Dysplasia and cytologic findings in 4,589 young women enrolled in Diethylstilbestrol-Adenosis (DESAD) Project. Am J Obstet Gynecol 1981;140:579-86.
18. Robboy SJ, Noller KL, O'Brien P, Kaufman RH, Townsend D, Barnes AB, et al. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA 1984;252:2979-83.
19. Jefferies JA, Robboy SJ, O'Brien PC, Bergstralh EJ, Labarthe DR, Barnes AB, et al. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am J Obstet Gynecol 1984;148:59-66.
20. Kaufman RH. Lower genital tract changes associated with in utero exposure to diethylstilbestrol. In: Apgar BS, Brotzman GL, Spitzer M, eds. Colposcopy, principles and practice: an integrated text and atlas. Philadelphia: Saunders, 2002:383-90.
21. Noller KL. Role of colposcopy in the examination of diethylstilbestrol-exposed women. Obstet Gynecol Clin North Am 1993;20:165-76.
22. Diethylstilbestroi. ACOG committee opinion: Committee on Gynecologic Practice. Number 131-December 1993. Int J Gynaecol Obstet 1994;44: 184.
23. Palmer JR, Hatch EE, Rao RS, Kaufman RH, Herbst AL, Noller KL, et al. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol 2001;154:316-21.
24. Goldberg JM, Falcone T. Effect of diethylstilbestrol on reproductive function. Fertil Steril 1999;72:1-7.
25. Swan SH. Pregnancy outcome in DES daughters. In: Giusti RM, ed. Report of the NIH workshop on long-term effects of exposure to diethylstilbestrol (DES). Washington, D.C.: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1992:42-9.
26. Kaufman RH, Adam E, Hatch EE, Noller K, Herbst AL, Palmer JR, et al. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol 2000;96:483-9.
27. Edelman DA, Badrawi HH. Contraception for women exposed in utero to diethylstilbestrol. Adv Contracept 1988;4:241-6.
28. Cosgrove MD, Benton B, Henderson BE. Male genitourinary abnormalities and maternal diethylstilbestrol. J Urol 1977;177:220-2.
29. Docimo SG, Silver RI, Cromie W. The undescended testicle: diagnosis and management. Am Fam Physician 2000;62:2037-44,2047-8.
30. Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 1995;332:1411-6.
31. Laitman CJ, Jonler M, Messing EM. The effects on men of prenatal exposure to diethylstilbestrol. In: Lipshultz U, Howards SS, eds. Infertility in the male. 3d ed. St. Louis: Mosby, 1997:268-79.
32. Driscoll SG, Taylor SH. Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol 1980;56:537-42.
33. Strohsnitter WC, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L, et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 2001;93:545-51.
34. Kaufman RH, Adam E. Findings in female offspring of women exposed in utero to diethylstilbestrol. Obstet Gynecol 2002;99:197-200.
35. Wilcox AJ, Umbach DM, Hornsby PP, Herbst AL. Age at menarche among diethylstilbestrol grand-daughters. Am J Obstet Gynecol 1995;173(3 pt 1): 835-6.
36. Klip H, Verloop J, van Gool JD, Koster ME, Burger CW, van Leeuwen FE, et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 2002;359:1102-7.
37. Whitesel JA. The case for diethytstilbestrol. J Urol 2003;169:290-1.